Institutional investors purchased a net $5.3 million shares of PDLI during the quarter ended March 2016 and now own 79.16% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIRST ASSET INVESTMENT MANAGEMEN... Bought 1.2 Million shares of PDL BioPharma Inc
OLD MUTUAL GLOBAL INVESTORS (UK)... Bought 254.2 Thousand shares of PDL BioPharma Inc